Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. (AKBA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AKBA · as of Jun 8, 2026
Key Statistics
Explore Akebia Therapeutics, Inc. Data
akba stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 63.6%
The AKBA analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $4.00, representing +327.53% upside from the current price of $0.94.
Competitors & Peers
akba competitorsAKBA
CMPX
CRVS
FDMT
GOSS
KALVStock Performance
Full HistoryAbout Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. established in 2007 and headquartered in Cambridge, Massachusetts, is a biopharmaceutical company focused on discovering and commercializing therapies for patients suffering…
what is akebia therapeutics, inc. · akba stock overview · akebia therapeutics, inc. company profile · who is akebia therapeutics, inc. ceo · akba NASDAQ · akebia therapeutics, inc. headquarters · akebia therapeutics, inc. business segments
About Stock Overview & Key Data
Akebia Therapeutics, Inc. (AKBA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 20, 2014. As of the latest trading session, AKBA stock price is $0.94, with a market capitalization of $251.0M. The stock has returned -76.17% over the past 12 months and -43.32% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Akebia Therapeutics, Inc. stock is Buy, with an average 12-month price target of $4.00. In fiscal year 2025, Akebia Therapeutics, Inc. reported revenue of $236.2M and net income of -$5.3M. For detailed data — including Akebia Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Akebia Therapeutics, Inc. (AKBA) stock price is $0.94. The stock is traded on NASDAQ under the ticker symbol AKBA. The 52-week range is $0.88 – $4.08.